// App-Quantinova.ai

: Patients Admitted With Type 2 Acute Myocardial Infarction Without Standard Modifiable Risk Factors Have Worse Outcomes Compared to Patients With Standard Modifiable Risk Factors

Researchers

Presenter

  • Balamrit Singh Sokhal

Principal Investigators

  • Andrija Matetic

  • Timir K Paul

  • Poonam Velagapudi

  • Ekaterini Lambrinou

  • Gemma A Figtree

  • Muhammad Rashid

  • Saadiq Moledina

  • Vassilios Vassiliou

  • Christian D Mallen

  • Mamas Mamas

Medical Centers

  • Cntr for Prognosis Rsch, Keele Cardiovascular Rsch Group, Newcastle Under-Lyme, United Kingdom

  • CYPRUS UNIVERSITY OF TECHNOLOGY, Limassol, Cyprus

  • Cntr for Prognosis Rsch, Keele Cardiovascular Rsch Group, Newcastle Under-Lyme, United Kingdom

  • University of Nebraska Medical Center, Omaha, NE

  • Sch of Medicine, Keele Univ, Newcastle Under-Lyme, United Kingdom

  • Univ of Sydney, Australia, St Leonards, Australia

  • Med Sch, Univ of East Anglia

  • Cntr for Prognosis Rsch, Keele Cardiovascular Rsch Group, Newcastle Under-Lyme, United Kingdom

  • Univ of Tennessee Nashville, Nashville, TN

Locations

  • United States

  • Australia

  • Cyprus

  • Croatia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Ischemic stroke

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved